Impact BioMedical, Inc. (IBO) Stock Statistics & Valuation Metrics
Total Valuation
Impact BioMedical, Inc. has a market cap or net worth of $32.83M. The enterprise value is $7.19T.
- Market Cap
- $32.83M
- Enterprise Value
- $7.19T
Share Statistics
Impact BioMedical, Inc. has 8,640,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,640,000
- Owned by Insiders
- 11.51%
- Owned by Institutions
- 0.86%
Financial Efficiency
Impact BioMedical, Inc.’s return on equity (ROE) is -0.94 and return on invested capital (ROIC) is -21.59%.
- Return on Equity (ROE)
- -0.94
- Return on Assets (ROA)
- -0.68
- Return on Invested Capital (ROIC)
- -21.59%
- Return on Capital Employed (ROCE)
- -0.26
- Revenue Per Employee
- 16.00K
- Profits Per Employee
- -5.92M
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 6.73
Valuation Ratios
The current PE Ratio of Impact BioMedical, Inc. is -3.26. Impact BioMedical, Inc.’s PEG ratio is -0.02.
- PE Ratio
- -3.26
- PS Ratio
- 978.86
- PB Ratio
- 3.18
- Price to FCF
- -67.44
- Price to Operating Cash Flow
- -67.44
- PEG Ratio
- -0.02
Income Statement
In the last 12 months, Impact BioMedical, Inc. had revenue of 32.00K and earned -11.84M in profits. Earnings per share was -4.80.
- Revenue
- 32.00K
- Gross Profit
- -392.00K
- Operating Income
- -4.27M
- Pretax Income
- -14.45M
- Net Income
- -11.84M
- EBITDA
- -12.51M
- Earnings Per Share (EPS)
- -4.80
Cash Flow
In the last 12 months, operating cash flow was -508.00K and capital expenditures 0, giving a free cash flow of -508.00K billion.
- Operating Cash Flow
- -508.00K
- Free Cash Flow
- -508.00K
- Free Cash Flow per Share
- -0.06
Dividends & Yields
Impact BioMedical, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.45%
- Earnings Yield
- 2.25%
Stock Price Statistics
- Beta
- 2.55
- 52-Week Price Change
- -40.61%
- 50-Day Moving Average
- 5.18
- 200-Day Moving Average
- 6.28
- Relative Strength Index (RSI)
- 46.69
- Average Volume (3m)
- 16.25K
Financial Position
Impact BioMedical, Inc. as a current ratio of 0.35, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.35
- Quick Ratio
- 0.30
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- -5.38
Taxes
In the past 12 months, Impact BioMedical, Inc. has paid -2.58M in taxes.
- Income Tax
- -2.58M
- Effective Tax Rate
- 0.18
Enterprise Valuation
Impact BioMedical, Inc. EV to EBITDA ratio is -87.33, with an EV/FCF ratio of -68.94.
- EV to Sales
- 1000.55
- EV to EBITDA
- -87.33
- EV to Free Cash Flow
- -68.94
- EV to Operating Cash Flow
- -68.94
Balance Sheet
Impact BioMedical, Inc. has $10.00K in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.00K billion.
- Cash & Marketable Securities
- $10.00K
- Total Debt
- $0.00
- Net Cash
- $10.00K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.28
Margins
Gross margin is -1111.43%, with operating margin of -14562.86%, and net profit margin of 2254.29%.
- Gross Margin
- -1111.43%
- Operating Margin
- -14562.86%
- Pretax Margin
- -5154.29%
- Net Profit Margin
- 2254.29%
- EBITDA Margin
- -1145.71%
- EBIT Margin
- -4411.43%
Analyst Forecast
The average price target for Impact BioMedical, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 400.00%
- EPS Growth Forecast
- 97.00%
Scores
- Smart Score
- 3
- AI Score
- ―
